Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
NCT06071377
This study is recruiting at 8 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Sickle Cell Trait
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Alliance for Sickle Cell Centers
- Last updated on ClinicalTrials.gov
- October 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama · Birmingham, AL
Delaware · 1
- Nemours Children's Hospital · Wilmington, DE
Indiana · 1
- Indiana University · Indianapolis, IN
Michigan · 1
- Functional Fluidics · Detroit, MI
North Carolina · 3
- University of North Carolina · Chapel Hill, NC
- Duke University · Durham, NC
- East Carolina University · Greenville, NC
Texas · 1
- UT Health Houston · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.